Article
Suppressor of cytokine signaling 1 gene mutation status as a prognostic biomarker in classical Hodgkin lymphoma.
Oncotarget - 6 Oct 2015
Lennerz Jochen K, Hoffmann Karl, Bubolz Anna-Maria, Lessel Davor, Welke Claudia, Rüther Nele, Viardot Andreas, Möller Peter
Abstract excerpt
Suppressor of cytokine signaling 1 (SOCS1) mutations are among the most frequent somatic mutations in classical Hodgkin lymphoma (cHL), yet their prognostic relevance in cHL is unexplored. Here, we performed laser-capture microdissection of Hodgkin/Reed-Sternberg (HRS) cells from tumor samples in a cohort of 105 cHL patients. Full-length SOCS1 gene sequencing showed mutations in 61% of all cases (n = 64/105)....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
